What are the absolute contraindications to prescribing nimesulide?

An absolute contraindication includes use in children under 12 years of age for oral formulations. Nimesulide's clinical use is restricted due to the risk of severe hepatotoxicity and liver failure; consequently, it is banned in several countries, especially for pediatric use.

Which drugs have clinically significant interactions with nimesulide?

Nimesulide should not be co-administered with other NSAIDs. Concomitant use with glucocorticoids, anticoagulants, methotrexate, bisphosphonates, and low-dose aspirin significantly increases the risk of NSAID-induced gastropathy and bleeding.

What core mechanism distinguishes Nimesulide from classic NSAIDs?

The drug acts pleiotropically: in addition to preferentially inhibiting COX-2, it suppresses type IV phosphodiesterase, inhibits cartilage-degrading metalloproteinases, and reduces the production of tumor necrosis factor-alpha (TNF-α).

What are the main limitations and risks associated with prescribing this drug?

The course of treatment is strictly limited to a maximum of 15 days. The primary severe risk is hepatotoxicity, which can lead to hepatic failure, particularly in pediatric patients.

How does Nimesulide affect articular cartilage?

Nimesulide is chondroneutral: it suppresses matrix metalloproteinases that degrade cartilage and generally exerts a neutral effect on joint tissues without causing direct damage.

Home › Pharmacology › Nimesulide

Nimesulide

*Nimesulidum*

For medical students2 min readUpdated 2026-10-10

Nimesulide is a modern non-steroidal anti-inflammatory drug (NSAID) with prominent anti-inflammatory and analgesic effects. It is classified as a preferentially selective COX-2 inhibitor and is used to manage various acute pain syndromes.

Drug ClassPreferentially selective COX-2 inhibitor

Treatment DurationLimited, maximum of 15 days

Major RiskHepatotoxicity and hepatic failure

JointsChondroneutral, no harm to cartilage

Complex Mechanism of Action

The pharmacological effects of Nimesulidum stem from multiple biochemical targets. The drug not only blocks COX-2, but also inhibits type IV phosphodiesterase (PDE4) and matrix metalloproteinases (MMPs)—enzymes that degrade articular cartilage.

In addition, the active substance suppresses the synthesis and release of TNF-α (tumor necrosis factor-alpha), decreases neutrophil activity, and potentially interacts with glucocorticoid receptors. This multi-level approach provides a potent anti-inflammatory outcome with a reduced incidence of certain adverse reactions compared to non-selective NSAIDs.

Indications for Use

The drug is widely recognized for its ability to rapidly control inflammation and pain of various origins. Main clinical indications include:

Rheumatic diseases involving both articular and periarticular tissues.
Various pain syndromes, including dental pain, dysmenorrhea, and somatic pain.

Safety Profile and Limitations

Key advantages of Nimesulidum include low gastrointestinal toxicity and chondroneutrality—meaning it lacks a negative impact on articular cartilage.

Nevertheless, its safety profile carries critical caveats:

Side Effects: Dyspeptic symptoms (nausea, epigastric pain), central nervous system reactions (headache, dizziness), and allergic manifestations may occur.
Time Restrictions: The total duration of continuous treatment must not exceed 15 days.
Serious Risks: The drug carries a potential risk of hepatotoxicity (ranging up to severe hepatic failure). Due to this risk, the drug is contraindicated in pediatric populations and is completely banned in several countries.

Mnemonic

Nimesulide: 15 days max, and protect the liver!

Frequently asked questions

What are the absolute contraindications to prescribing nimesulide?: An absolute contraindication includes use in children under 12 years of age for oral formulations. Nimesulide's clinical use is restricted due to the risk of severe hepatotoxicity and liver failure; consequently, it is banned in several countries, especially for pediatric use.
Which drugs have clinically significant interactions with nimesulide?: Nimesulide should not be co-administered with other NSAIDs. Concomitant use with glucocorticoids, anticoagulants, methotrexate, bisphosphonates, and low-dose aspirin significantly increases the risk of NSAID-induced gastropathy and bleeding.
What core mechanism distinguishes Nimesulide from classic NSAIDs?: The drug acts pleiotropically: in addition to preferentially inhibiting COX-2, it suppresses type IV phosphodiesterase, inhibits cartilage-degrading metalloproteinases, and reduces the production of tumor necrosis factor-alpha (TNF-α).
What are the main limitations and risks associated with prescribing this drug?: The course of treatment is strictly limited to a maximum of 15 days. The primary severe risk is hepatotoxicity, which can lead to hepatic failure, particularly in pediatric patients.
How does Nimesulide affect articular cartilage?: Nimesulide is chondroneutral: it suppresses matrix metalloproteinases that degrade cartilage and generally exerts a neutral effect on joint tissues without causing direct damage.

Go deeper

Comparison of COX-1 and COX-2 selectivity among various NSAIDs
The role of type IV phosphodiesterase (PDE4) in inflammatory pathways
Mechanisms of drug-induced hepatotoxicity
The impact of metalloproteinases on articular cartilage degradation in arthritis
Special considerations for anti-inflammatory therapy in rheumatic diseases